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ABSTRACT 
Introduction: The aim of this study was to evaluate the effectiveness of re-education in the 
insulin injection technique for glycemic control. 
Methods: A preliminary experimental study was performed with 87 insulin-treated diabetic 
outpatients (11 with type 1 diabetes, 76 with type 2 diabetes; 43 men, 44 women). All patients 
had been treated with insulin for more than 3 years. After answering questions about the 
insulin injection technique, the patients’ knowledge levels were scored. Correct answers and 
explanation sheets were subsequently given to all patients. The physicians in charge gave a 
short lecture and provided 10 minutes of individual advice. Two, three, and four months after 
re-education the HbA1c and glycoalbumin levels were measured. 
Results: The mean HbA1c levels of almost all patients significantly improved from 
7.46±0.09% to 6.73±0.10% (P <0.01), and the mean glycoalbumin levels significantly 
improved from 22.76±0.50% to 20.26±0.68% (P <0.01). Twenty-five patients demonstrated a 
poor understanding (score of ≤6 points) and showed a significant decrease in the HbA1c level 
from 7.62±0.20% to 6.71±0.21% (P = 0.02). Forty-three patients demonstrated a moderate 
understanding (score of 7 or 8 points) and showed a decrease in the HbA1c level from 
7.40±0.13% to 6.68±0.07% (P = 0.07). Finally, 19 patients demonstrated a good 
understanding (score of ≥9 points) and showed a slight decrease in the HbA1c level from 
7.38±0.15% to 6.93±0.12% (P = 0.09). Patients with a poor understanding showed the largest 
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decrease in the mean level of HbA1c. 
Conclusion: Re-education in the insulin injection technique led to an improvement in 
glycemic control in insulin-treated diabetic patients, especially in those with a poor 
understanding of the insulin injection technique. More attention should be paid to these 
strategies for outpatients. 
Keywords: diabetes mellitus; glycemic control; insulin; insulin injection technique; 
re-education 
INTRODUCTION 
Glycemic control through insulin treatment is appropriate for both type 1 and type 2 diabetes 
if control through oral therapy is inadequate or internal insulin secretion has decreased [1]. In 
particular, severe glycemic control through intensive insulin treatment (three or more daily 
insulin treatment) has been shown to lower the occurrence/progress of complications in 
diabetic patients [2, 3]. 
At present, approximately 700,000–800,000 of 8.9 million diabetic patients in Japan 
are receiving insulin treatment [4]. About 4 million people in the United States and about 3.8 
million people in Europe are using insulin, and the number of such patients continues to 
increase [5]. 
The development of insulin preparations and injectors has contributed significantly to 
the progress in insulin treatment, and pen-type insulin injectors are now common [6]. The 
convenience and ease of use of injectors has improved dramatically, and the introduction of 
outpatient insulin treatment is actively being promoted [7]. 
However, the act of injecting oneself with drugs is not a normal activity for many 
patients and can thus cause anxiety. Furthermore, instruction in self-injection is often only 
given at the start of insulin treatment and often patients cannot understand how to self-inject 
insulin perfectly [8]. Recently, there has been an emergence of many patients with a long 
history of insulin treatment, as well as many elderly patients, and continuous instruction is 
needed [9]. Therefore, it is important that medical staff give step-by-step instructions on the 
key points of the injection technique and confirm that the patient has understood the 
instructions correctly [10].  
In addition, when self-injection of insulin is conducted at home, glycemic control can 
fluctuate because of various factors related to daily life [11]. A high self-management 
capability is thus required to maintain favorable glycemic control. To that end, appropriate 
clinical instruction suited to individual characteristics is needed. Patients who conduct 
self-injections of insulin under self-management must be knowledgeable in the reasons behind 
problems associated with glycemic control. 
Therefore, this study evaluated outpatients at the Dokkyo Medical University Hospital 
performing self-injections of insulin and investigated the degree of individual understanding 
of injection techniques. Re-education was then conducted with an emphasis on points that 
were poorly understood and techniques that were prone to mistakes or omissions. The impact 
of this re-education on glycemic control was then studied. 
 
METHODS 
Study Population 
This study included 87 outpatients with diabetes performing self-injections of insulin and 
treated at a single outpatient clinic (Dokkyo Medical University Hospital, Tochigi, Japan). 
Patients were included in the study if they had been treated with insulin for more than 3 years, 
and could administer insulin injection by themselves. They used 31-G needle before this study 
and didn't change the needle. All procedures followed were in accordance with the ethical 
standards of the responsible committee on human experimentation (institutional and national) 
and with the Helsinki Declaration of 1975, as revised in 2000 and 2008. Informed consent 
was obtained from all patients for being included in the study. Patients glycemic levels were 
monitored for any adverse events (e.g. problems with glycemic control) and insulin levels 
were adjusted as necessary. 
Study Design 
Techniques for self-injection of insulin were confirmed using a questionnaire (Figure 1), and 
re-education in insulin injection techniques was conducted once a month using an educational 
manual (Figure 2). The nine items related to the insulin self-injection technique are described 
as follows. 
Any air present in the insulin cartridge should be removed. The presence of a large 
amount of air inside the cartridge reportedly prevents an appropriate amount of insulin from 
being injected [12]. A study in Japan reported that the smaller the amount of air mixed in the 
cartridge, the better the accuracy of the injector [12]. In addition, storing the injector with the 
needle still attached results in the entrance of air from the needle tip and an increase in the 
number of air bubbles over time; thus, needles must be detached immediately after use. 
Freezing and thawing of unused insulin preparations can also cause the formation of air 
bubbles, in which case an air bubble is generated due to the temperature change. Therefore, 
patients were instructed to ensure that unused insulin preparations were not frozen and were 
instead kept refrigerated at 2 to 8°C [13]. In addition, in cloudy insulin preparations, the 
introduction of air has reportedly changed the concentration of the insulin [14]. 
A trial injection should be performed. A trial injection is necessary to let air bubbles 
out of the cartridge and the equipped needle. This is also an important step for confirming that 
the needle is installed properly and that the injector works properly. 
Insulin should be injected into the abdomen. Subcutaneous injection into the 
abdomen is most common because absorption of insulin is quick [15], it is least affected by 
exercise [16, 17] and outside temperature [18-20], and it is less painful compared with other 
sites [7]. It has also been pointed out that injecting into the abdomen lessens blood glucose 
fluctuations [21]. 
The stiffness of the injection area should be checked. Stiffness in the area where 
insulin is injected is the result of expansion of fat tissue, and it often occurs when injections 
are repeated in the same area. This not only promotes fat synthesis in the insulin-injected area, 
but has also been observed to involve the immune system [22]. When an injection is made 
into an area with expanded fat tissue, the injection is less painful, but a delay occurs in insulin 
absorption; thus, the effect of the insulin is not fully manifested [23]. We advised patients to 
inject into the same location every time and to avoid skin abnormalities by changing locations 
by 2 to 3 cm. Because frequent insulin injections have become common, there have been 
reports that approximately half of patients with type 1 diabetes experience stiffness [24], that 
HbA1c levels are significantly higher in these patients than in patients without stiffness [25], 
and that HbA1c levels improve by changing the location of injections [22]. 
The skin should be pinched while injecting. The skin structure of human beings 
comprises the epidermis, dermis, hypodermis, and musculature. Because the epidermis and 
dermis contain many immune, nerve, and lymph cells, an intradermal injection of insulin may 
stimulate nerve endings and increase pain or result in an increased immune response to the 
insulin [26]. An intramuscular injection will double the rate of insulin absorption [27]. 
Conversely, the hypodermis comprises mostly fat and is well suited for insulin injections. 
Some thin patients have almost no subcutaneous fat at all, and we instructed such patients to 
pinch the skin while injecting to ensure stable absorption. 
The injection should be at a straight angle. If the angle of the injection is not 
perpendicular to the skin, the insulin may be intradermally injected [28]. We instructed 
patients to perform a perpendicular injection. 
The injection button should be pressed in gently. Some time is required for the insulin 
to completely flow into the injected area. We instructed patients to inject by calmly and gently 
pushing in. 
The needle should be pulled out slowly. As the diameter of the injector needle 
decreases, injection resistance increases and the time required for insulin to flow into the site 
lengthens [29]. For complete inflow of insulin, the patient must wait for a certain period of 
time after pushing the injector button, and it is important that insulin does not leak from the 
needle tip after pulling the needle out. Because a thin 31-G needle was used for this study, we 
instructed patients to wait for 15 seconds after pushing the injector button. 
The needle should be pulled out while the injection button is held down. Continuing to 
push the injector button whilst pulling the needle out will prevent blood from mixing with the 
insulin (so-called reflux). The most likely reason for reflux is releasing the finger from the 
injector button before pulling the needle out, which lowers the pressure inside the cartridge 
[30]. 
We didn't re-educate a change in diet or the rate of self-glucose monitoring during this 
study period. We also believe that it shows more accurate educational effect by using two 
indices, HbA1c and glycoalbumin. 
HbA1c and glycoalbumin levels were used as glycemic control indices These were 
measured before and 2, 3, and 4 months after re-education. HbA1c was measured using a 
Determiner HbA1c Kit
®
 (Kyowa Medex Co., Ltd., Tokyo, Japan), and glycoalbumin was 
measured using a Lucica GA-L Kit
®
 (Asahi Kasei Pharma Co., Ltd., Tokyo, Japan). During 
this period, insulin units were not changed with the exception of frequent low glycemic levels 
and severely high glycemic levels. 
Of the insulin self-injection techniques, nine items were scored (Figure 1). These 
scores were totaled, and a dispersion chart was produced according to the scores. The 
dispersion chart was divided into three groups (Figure 3), and changes in the HbA1c level was 
observed for each group. 
Statistical Analysis 
The results are presented as mean ± SE. Comparisons of two groups were made using the 
unpaired t test for continuous variables. Two-tailed P values of <0.05 were considered 
statistically significant. All data were analyzed using JMP7 (SAS Institute Inc., NC, USA). 
 
RESULTS  
Clinical Characteristics of the Subjects 
Eighty-seven patients with diabetes were enrolled in the study. Patient characteristics are 
shown in Table 1. The breakdown of the number of daily insulin injections is shown in Table 
1. 
HbA1c and Glycoalbumin Levels for all groups 
The mean HbA1c level the start of re-education was 7.46±0.09%. The level significantly 
decreased to 7.11±0.09% (P <0.01) 2 months after re-education, to 7.05±0.11% (P <0.01) 3 
months after re-education, and to 6.73±0.10% (P <0.01) 4 months after re-education.  
The mean glycoalbumin level before re-education was 22.76±0.50%. The level 
significantly decreased to 21.85±0.41% (P <0.01) 2 months after re-education, to 
21.28±0.56% (P <0.01) 3 months after re-education, and to 20.26±0.68% (P <0.01) 4 months 
after re-education (Figure 4). 
During this 4 month period, 11 patients’ insulin units were decreased because of low 
glycemic levels, and two patients’ insulin units were increased because of problems with 
glycemic control. 
HbA1c and Glycoalbumin Levels by Group 
The breakdown of the total scores for the nine items related to self-injection techniques was as 
follows: 7 patients with 4 points, 6 with 5 points, 12 with 6 points, 23 with 7 points, 20 with 8 
points, 11 with 9 points, and 8 with 10 points. The 25 patients with 4 to 6 points were 
classified as Group I (poor understanding), the 43 patients with 7 or 8 points were classified 
as Group II (moderate understanding), and the 19 patients with 9 or 10 points were classified 
as Group III (good understanding; Figure 3). 
The mean HbA1c level in Group I was 7.62±0.20% the start of re-education and 
showed significant improvement to 7.37±0.18% (P <0.01) 2 months after re-education, to 
7.25±0.18% (P <0.05) 3 months after re-education, and to 6.71±0.21% (P <0.05) 4 months 
after re-education. 
The mean HbA1c level in Group II decreased from 7.40±0.13% before re-education to 
6.87±0.10% (P <0.01) 2 months after re-education, to 6.90±0.18% (P <0.06) 3 months after 
re-education, and to 6.68±0.12% (P = 0.07) 4 months after re-education. A significant 
decrease was only observed 2 months after re-education. 
The mean HbA1c level in Group III decreased from 7.38±0.15% at the start of 
re-education to 7.36±0.17% (P = 0.63) 2 months after re-education, to 7.35±0.30% (P = 0.81) 
3 months after re-education, and to 6.93±0.17% (P = 0.09) 4 months after re-education. A 
downward trend was shown, but none of the changes were statistically significant (Figure 5). 
 
DISCUSSION 
In this study, re-education in insulin self-injection techniques was performed once a month for 
approximately 4 months. HbA1c and glycoalbumin levels decreased significantly as a result of 
re-education. Patients with a poor understanding of self-injection techniques had high levels 
of HbA1c prior to re-education. Furthermore, patients with a poor understanding of 
self-injection techniques had a greater rate of decrease in the HbA1c level as a result of 
re-education. A correlation reportedly exists between knowledge of diabetes and HbA1c levels 
when education/instruction on diabetes is instituted over a long period of time [31]. Similarly, 
the present study indicated that repeated instruction in insulin self-injection techniques has a 
favorable effect on glycemic control. 
This study has certain limitations. This study did not have a control group because it 
used all outpatients who matched the inclusion criteria at the Dokkyo Medical University 
Hospital. We know that often a patient's behavior is changed by result of re-education. 
Therefore, we didn't re-educate change in diet, exercise, and the rate of self-glucose 
monitoring during this study period. 
This study raises the possibility that problems with the insulin injection technique are 
one reason for poor glycemic control. The most common problems observed were repeatedly 
injecting into the same place, which resulted in stiffness, and pulling the needle out too 
quickly. Through repeated instruction in correct insulin injection methods, improvement in 
glycemic control was observed. 
 
CONCLUSION 
In conclusion, we have highlighted the importance of re-education in insulin self-injection 
techniques. Learning insulin self-injection techniques is a great burden for many patients [25]. 
Efforts should be made to understand patients’ personalities and lifestyles and provide patient 
instruction that explains each step of the technique, as well as the reason for each step, one by 
one. The ability to increase the patient’s self-management capability as a result of this 
re-education would be a welcome development. We believe that it will also be important to 
move forward as a team by communicating with other medical staff members, such as nurses 
and pharmacists. 
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Table 1 Patients’ clinical characteristics 
Average age 59.3±1.7 years 
Male/female ratio 43/44 (N = 87) 
Health status: type 1 or 2 diabetes 11/76 
Average length of diabetes 15.8±1.0 years 
Average length of insulin use 6.6±0.6 years 
Average number of injections 2.75±0.10 years 
Number of daily injections Number 
1 5 
2 38 
3 20 
4 19 
5 4 
Data are presented as n or mean ± standard error. 
  
Figure 1 The Questionnaire Used in this Study 
Answers were scored with 1 point assigned to a “Yes” answer and 0 points assigned to a “No” 
answer. However, for Question 8, 0 points were assigned to 0 to 5 seconds, 1 point to 6 to 14 
seconds, and 2 points to 15 or more seconds.  
Figure 2 The Instructions Given to Patients in this Study 
 Figure 3 Patient Groups According to Point Score. We divided the patients into three 
groups (I, II, III) according to point scores. The 25 patients with 4 to 6 points were classified 
as Group I (poor understanding), the 43 patients with 7 or 8 points were classified as Group II 
(moderate understanding), and the 19 patients with 9 or 10 points were classified as Group III 
(good understanding. 
  
 Figure 4 Rate of Decrease of Mean HbA1c and Glycoalbumin Levels. The results shown 
are given as the mean ± standard error. **Significant difference between the rate before and 
after re-education (P <0.01). GA: glycoalbumin; HbA1c: hemoglobin A1c. 
  
 Figure 5 Rate of Decrease of HbA1c Levels. The results shown are given as mean ± 
standard error. Group I (poor understanding) showed a significant decrease in HbA1c levels 
by re-education in all periods (The P value were: 2 months later (P <0.01), 3 months later (P 
<0.05), and 4 months later (P <0.05)). Group II (moderate understanding) showed a 
significant decrease 2 months later. (The P value were: 2 months later (P <0.01), 3 months 
later (P <0.06), and 4 months later (P = 0.07)). Group III (good understanding) did not show a 
significant decrease. (The P value were 2 months later (P = 0.63), 3 months later (P = 0.81), 
and 4 months later (P=0.09)). *Significant difference between the rate before and after 
re-education (P <0.05). **Significant difference between the rate before and after 
re-education (P <0.01). 
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